Product Images Simvastatin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 13 images provide visual information about the product associated with Simvastatin NDC 70518-3630 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Footnote for Table 3 - Footnote for Table 3
The text describes the results of a chemical assay that could potentially be indicative of several inhibitors of a certain enzyme, including ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone. The text also explains that simvastatin acid is the p-hydroxyacid of simvastatin. However, it is unclear whether grapefruit juice affects simvastatin pharmacokinetics as the effect of different amounts of grapefruit juice has not been studied. The text also provides information on the administration of grapefruit juice and simvastatin during an experiment.*
Remedy_Label - Remedy Label
Simvastatin is a medication available in tablet form with a strength of 20 mg. Each pack contains 30 tablets. The medication is only available with a valid prescription. The packaging includes the NDC number, RX only label, manufacturer details, and storage instructions. The package insert should be consulted before use. The medication should be stored at a temperature between 20-25°C (68-77°F) and should be kept away from children. The repackaging of the medication has been done by RemedyRepack Inc. located in Indiana, PA.*
MM2 - Simvastatin 20mg 70518 3630 01
This is a prescription drug called Simvastatin, which is available in a bottle of 90 tablets. The package insert contains information about how to use it. It is important to keep the medication out of the reach of children, and it should be stored at room temperature. The product is repackaged by RemedyRepack Inc. with a specific lot number and NDC number. The expiration date is not available.*
Figure 9 - simvastatin 10
table2 - simvastatin 2
The table shows adverse reactions reported by patients treated with Simvastatin in comparison to those who took Placebo. It reports the percentage of patients who reported the reactions with a frequency of greater than or equal to 2%. The reactions are categorized by the body system that was affected, with some examples being: Edema/swelling, Atrial fibrillation, Diabetes mellitus, Bronchitis, Eczema, and Infection, urinary tract.*
Structure - simvastatin 3
table 3 - simvastatin 4
table 4 - simvastatin 5
Figure 5 - simvastatin 6
This appears to be a table with data on major vascular events and major coronary events in patients taking Simvastatin versus Placebo, categorized by different patient characteristics such as presence of cardiovascular diseases and other related conditions. However, without more context on the units of measurements and other important details, it is difficult to provide a more specific description.*
Figure 6 - simvastatin 7
Figure 7 - simvastatin 8
Figure 8 - simvastatin 9
table 1 - table1
This appears to be a table showing drug interactions that increase the risk of myopathy/rhabdomyolysis. The table includes a list of drugs that can interact with Simvastatin, a medication used to lower cholesterol levels, leading to muscle damage. The list provides recommendations for prescribing medications, including which drugs to avoid or only take at lower doses when taking Simvastatin. It also lists drugs that can increase the risk of muscle damage, such as strong CYP3A4 inhibitors, HIV protease inhibitors, cyclosporine, and certain antibiotics. The last line appears to be garbled and therefore not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.